Cargando…

737. The Prevalence of Diagnosed Chronic Lung Disease in US Infants by Gestational Age: Implications for RSV Policy

BACKGROUND: Perinatal chronic lung disease (CLD), previously referred to as bronchopulmonary dysplasia (BPD), is associated with preterm birth and occurs rarely among term infants. Children with CLD are at elevated risk for severe RSV disease in the first 2 years of life. Definitions of CLD/BPD iden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrose, Christopher S, Jiang, Xiaohui, Mavunda, Kunjana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255616/ http://dx.doi.org/10.1093/ofid/ofy210.744

Ejemplares similares

Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age
por: Mavunda, K., et al.
Publicado: (2021)

Current State of Respiratory Syncytial Virus Disease and Management
por: Chatterjee, Archana, et al.
Publicado: (2021)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

2641. Nirsevimab binding-site conservation in RSV F protein between 2015 and 2022: The US OUTSMART-RSV surveillance study
por: Morehouse, Christopher A, et al.
Publicado: (2023)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

735. Severity and Healthcare Costs of Respiratory Syncytial Virus Hospitalizations in US Preterm Infants Born at 29–34 Weeks Gestation: 2014–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2019)

728. Regional Validation of Distinct RSV Seasonality Thresholds for Antigen and PCR Testing
por: Ambrose, Christopher S, et al.
Publicado: (2018)

901. MEDI8897 Prevents Serious RSV Disease in Healthy Preterm Infants
por: Pamela Griffin, Mary, et al.
Publicado: (2019)

Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change
por: Krilov, Leonard R., et al.
Publicado: (2021)

1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
por: Martinon-Torres, Federico, et al.
Publicado: (2018)

89. The Impact of Nirsevimab on an RSV Season in All Infants: Data From The HARMONIE Study
por: Faust, Saul N, et al.
Publicado: (2023)

1942. Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV among US Infants
por: Hanau, Ahuva, et al.
Publicado: (2023)

Characterization of Circulating RSV Strains Among Patients In The Outsmart RSV Program During the 2015–16 Winter Viral Season in the United States
por: Pastula, Susan, et al.
Publicado: (2017)

1019. Respiratory Syncytial Virus (RSV) Diagnoses in Hospitalized Patients Increases when Additional Specimen Types are Added to Nasopharyngeal Swab: Results from the RSV in Adults Multispecimen Study
por: Ramirez, Julio, et al.
Publicado: (2023)

737. Geographic Clustering of Travel-acquired Infections in Ontario, Canada, 2008-2020
por: Harish, Vinyas, et al.
Publicado: (2021)

A Mid-Turbinate Swab Appears Comparable to Nasopharyngeal Swabs for Quantitative Detection of RSV in Infants
por: Blaschke, Anne J, et al.
Publicado: (2017)

117. Effect of Nasopharyngeal Pneumococcal Carriage on RSV and hMPV Illness Severity in Infants in Nepal
por: Murray, Alastair, et al.
Publicado: (2018)

415. Airway Gene-Expression Classifiers for Respiratory Syncytial Virus (RSV) Disease Severity in Infants
por: Caserta, Mary T, et al.
Publicado: (2019)

2208. Rates of Medically-Attended RSV among US Adults: A Systematic Review and Meta-Analysis
por: McLaughlin, John M, et al.
Publicado: (2022)

Prevalence of infant bronchiolitis‐coded healthcare encounters attributable to RSV
por: Turi, Kedir N., et al.
Publicado: (2018)

2592. Lung Function as an Indicator of Vaccine Enhanced RSV Disease in Cotton Rats
por: Jones, Crystal, et al.
Publicado: (2019)

133. validation of a Global Respiratory Severity Score in Infants with Primary RSV Infection
por: Qiu, Xing, et al.
Publicado: (2020)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

118. Nasopharyngeal (NP) Bacterial Detection in Infants With Respiratory Syncytial Virus (RSV) Infection: Impact on Clinical Outcomes
por: Diaz, Alejandro, et al.
Publicado: (2018)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

1943. RSV Prophylaxis for 29-34 Gestational Preemies. Are Current Guidelines Justified? Lessons from an Israeli Multicenter Off-seasonal Study
por: Armoni Domany, Keren, et al.
Publicado: (2023)

2657. Investigation of Respiratory Syncytial Virus (RSV) Stability in Nasal Aspirate Collected from RSV Infected Patients
por: Yamamoto, Atsuko, et al.
Publicado: (2023)

2313. Influenza and Respiratory Syncytial Virus (RSV) Surveillance in the US Department of Veterans Affairs (VA): 2018–2019 Season
por: Lucero-Obusan, Cynthia, et al.
Publicado: (2019)

2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level
por: Comeaux, Christy A, et al.
Publicado: (2022)

Is This a 737 Max Moment for Brolucizumab?
por: Rosenfeld, Philip J., et al.
Publicado: (2020)

2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants
por: Mejias, Asuncion, et al.
Publicado: (2018)

A Single Dose Monoclonal Antibody (mAb) Immunoprophylaxis Strategy to Prevent RSV Disease in All Infants: Results of the First in Infant Study with MEDI8897
por: Domachowske, Joseph B, et al.
Publicado: (2017)

PT737. Association between overweight and the risks of lifetime psychiatric disorders and suicidality: a general population-based study in Korea
por: Kim, Byung-Soo, et al.
Publicado: (2016)

Correlation of lung mechanics with saturated phosphatidylcholine ratios and surfactant protein A in bronchoalveolar lavage fluid from infants with RSV induced respiratory failure
por: Tibby, SM, et al.
Publicado: (1999)

Impact of the 2014 American Academy of Pediatrics Policy on RSV Hospitalization in Preterm Infants in the United States
por: Goldstein, Mitchell, et al.
Publicado: (2021)

2353. Respiratory Syncytial Virus (RSV) in Preterm Infants: Epidemiology, Clinical Pattern, and Risk Factors in a Pediatric Hospital in Argentina
por: Gentile, Angela, et al.
Publicado: (2018)

2198. Healthcare Utilization During Acute Medically Attended Respiratory Syncytial Virus (RSV) Episodes among Infants in the United States
por: Gantenberg, Jason, et al.
Publicado: (2022)

1526. The economic impact of respiratory syncytial virus (RSV) in infants in the United States: systematic literature review
por: Bowser, Diana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8u4tfjorepvnmk6f6d0ait05cb